Biography

Dr. Chawarska has received her clinical and research training at Yale. She is a leading expert in research on identifying markers of autism spectrum disorders (ASD) and novel treatment targets in infancy. In her clinical practice, Dr. Chawarska specializes in early diagnosis of ASD as well as developmental follow-up of infants at risk for ASD due to familial factors (e.g., having an older sibling with ASD), genetic factors (e.g., having a syndrome related to ASD such as Fragile X), or due to prenatal or perinatal complications such as premature birth.

Education & Training

PhD

Yale University (2000)

MA

Jagiellomian Univ. (1986)

Post-Doctoral Fellowship

Yale University School of Medicine

Professional Service

Yale School of Medicine (2015 - Present)
Faculty Advisory Committee

Department of Defense (2014 - Present)
Panel member of the US Army Medical Research and Material Command Autism Research Program Integration Panel

Baby Sibling Research Consortium (2013 - Present)
Chairperson

Child Study Center (2007 - Present)
Advisory Committee

NICHD, NIMH, Autism Speaks (2007 - Present)
Grant Review Panel

Activities

Advances in studies of early expression of ASD: Infants at Genetic Risk for ASD
Budapest, Hungary (2013 - 2013)

What eye-tracking research tells us about development of infants at risk for autism?
Uppsala, Sweden (2012 - 2012)

Autism in Infancy: Perceptual, Attentional, and Social-Cognitive Features
Los Angeles, CA, United States (2012 - 2012)

Mailing Address

Modal Title

How will my information be used?

When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.

If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.

In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.